Skip to main content
. 2019 Jul 22;18(3):2977–2984. doi: 10.3892/ol.2019.10643

Figure 2.

Figure 2.

Silencing ROR1 together with erlotinib reduces cell proliferation of non-small cell lung cancer cell lines. (A) PC-9erlo and (B) NCI-H1975 cell lines were treated with erlotinib alone, erlotinib +20 nM siNC or erlotinib + 20 nM siROR1, and analyzed for growth inhibition using the MTS assay. Experiments were performed three times (n=3). Microscope images of (C) PC-9erlo and (D) NCI-H1975 cells in different treatment groups (magnification, ×100). ROR1, receptor tyrosine kinase-like orphan receptor 1; si, small interfering; NC, negative control; erlo, erlotinib.